Insider Activity Spotlight: Guttman‑McCabe Christopher’s June 15 Buying Surge

On 15 June 2026 the Chief Regulatory & Communications Officer of Anterix, Christopher Guttman‑McCabe, executed a substantial purchase of the company’s common stock. The officer acquired 117,018 shares—approximately 17 % of his post‑transaction holdings—at an average price of $79.16 per share. The transaction followed a pattern of high‑frequency trades that moved his position from 46,392 shares at the end of May to 169,244 shares by mid‑June.

Timing and Market Context

The purchase was recorded shortly after the market closed on a day marked by unprecedented social‑media activity (a 101 % increase above the weekly average). Despite the surge in online chatter, overall market sentiment remained neutral. The volume of the trade suggests a confidence‑driven maneuver rather than a defensive hedge, indicating that the officer is betting on the next wave of infrastructure contracts that Anterix is positioned to secure in the energy and transportation sectors.


What This Means for Investors

DimensionAssessment
Positive SignalInsider buying of this magnitude typically signals that insiders perceive the stock as undervalued relative to future growth prospects. Anterix’s recent 43.98 % monthly gain and 186.76 % year‑to‑date return reinforce the narrative that the company’s broadband initiatives are gaining traction.
Liquidity ConcernsAlthough the officer’s stake grew, he still holds 169,244 shares—a small fraction of the 1.5 billion‑share float—so the immediate risk of a large block sale is low. However, the pattern of frequent option exercises (several hundred thousand shares) could foreshadow future liquidity events.
Regulatory ScrutinyThe officer’s role in compliance raises questions about whether the purchase was timed to coincide with internal approvals or forthcoming regulatory filings. This could create a short‑term supply‑demand imbalance if a sale follows shortly thereafter.

Historical Context: A Pattern of Opportunistic Buying

A review of Guttman‑McCabe’s transactions over the past year shows a buy‑and‑hold strategy punctuated by occasional option exercises. Notable points include:

  • May 2025: Exercised 23,271 options.
  • May 2026: Purchased 4,926 shares at $0.00, reflecting the company’s option‑grant policy.
  • May 2026: Sold 1,426 shares when the price dipped below $60.

These actions demonstrate a long‑term commitment to Anterix’s vision, with a willingness to capitalize on short‑term volatility for incremental gains.


Broader Insider Landscape

The June 15 filing coincided with a flurry of activity from other executives:

ExecutiveRoleShares BoughtShares Sold
Ashe Gena LChief Legal Officer & Corporate Secretary> 30 000≈ 50 000
Lang Scott A.President & CEO139 31888 091
Cumulative insider holdings

The cumulative insider holdings now hover around 35 % of the outstanding shares, providing a stabilizing effect while raising questions about potential coordination among senior leaders.


Bottom Line for Stakeholders

  • Long‑term investors should view the officer’s fresh buying tranche as a green flag that insiders see upside in Anterix’s diversified telecom services.
  • Short‑term traders should monitor the high trading frequency and the recent spike in social‑media buzz, especially around earnings releases and major contract announcements.
  • As Anterix continues to roll out its broadband solutions, insider activity will likely remain a barometer of confidence and a subtle indicator of where the company’s leadership believes the next inflection point lies.

Transaction Summary (15 June 2026)

OwnerTransaction TypeSharesPrice per ShareSecurity
Guttman‑McCabe ChristopherBuy11 75025.75Common Stock
Guttman‑McCabe ChristopherBuy8 00032.50Common Stock
Guttman‑McCabe ChristopherBuy50 87634.40Common Stock
Guttman‑McCabe ChristopherBuy20 00037.42Common Stock
Guttman‑McCabe ChristopherBuy6 71542.14Common Stock
Guttman‑McCabe ChristopherBuy25 51149.39Common Stock
Guttman‑McCabe ChristopherSell35 32181.32Common Stock
Guttman‑McCabe ChristopherSell26 41182.27Common Stock
Guttman‑McCabe ChristopherSell16 38183.72Common Stock
Guttman‑McCabe ChristopherSell13 32484.29Common Stock
Guttman‑McCabe ChristopherSell11 750Stock Option (Right to Buy)
Guttman‑McCabe ChristopherSell8 000Stock Option (Right to Buy)
Guttman‑McCabe ChristopherSell50 876Stock Option (Right to Buy)
Guttman‑McCabe ChristopherSell20 000Stock Option (Right to Buy)
Guttman‑McCabe ChristopherSell6 715Stock Option (Right to Buy)
Guttman‑McCabe ChristopherSell25 511Stock Option (Right to Buy)
Ashe Gena LBuy11 00034.96Common Stock
Ashe Gena LBuy18 36849.39Common Stock
Ashe Gena LSell4 66182.50Common Stock
Ashe Gena LSell10 99682.50Common Stock
Ashe Gena LSell13 37581.04Common Stock
Ashe Gena LSell4 33682.14Common Stock
Ashe Gena LSell11 000Stock Option (Right to Buy)
Ashe Gena LSell18 368Stock Option (Right to Buy)
Lang Scott A.Buy63 78830.99Common Stock
Lang Scott A.Buy74 53034.96Common Stock
Lang Scott A.Sell39 62182.50Common Stock
Lang Scott A.Sell48 47082.50Common Stock
Lang Scott A.Sell63 788Stock Option (Right to Buy)
Lang Scott A.Sell74 530Stock Option (Right to Buy)
Fleischhauer MarkSell3 50079.83Common Stock
YAZDI MAHVASHSell7 00080.00Common Stock
YAZDI MAHVASHHolding250Common Stock
YAZDI MAHVASHHolding750Common Stock

All figures are taken from the 15 June 2026 insider trading disclosure.